Altman Peter 4

What Happened
Peter Altman, President & CEO (and Director) of BioCardia, acquired 5,000 shares on February 4, 2026. The filing reports a purchase (transaction code P) at $1.13 per share for a total reported value of $5,650. This was a straight purchase (a bullish signal in that insiders bought stock), not a sale or option exercise.

Key Details

• Transaction date: 2026-02-04; reported filing date: 2026-02-04 (timely filing).
• Price: $1.13 per share; Shares acquired: 5,000; Total value: $5,650.
• Transaction type: P = Purchase (open-market or private purchase as shown in the filing).
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes/plan references: none reported in provided data (no 10b5-1 plan, tax withholding, or other notations indicated).
• Accession #: 0001437749-26-003027 (SEC Form 4).

Context
Insider purchases are often watched by investors as a potential sign of confidence, but small-dollar buys like this ($5.7k) should be viewed in context with the insider’s overall holdings and company fundamentals. This filing appears timely and straightforward — an acquisition, not an option exercise or gift.